Gimv
Growth equityAntwerp · Growth–Late Stage · 11 people tracked
Find your way into Gimv
3,711 people in our graph share verified history with the Gimv team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Gimv invests in innovation and entrepreneurship, backing entrepreneurial and innovative companies through four strategic investment platforms shaped by societal trends: digitalisation & automation, electrification & energy efficiency, sustainable food & wellbeing, and healthcare. Its approach is built on a solid balance sheet, patient capital and a long-term view, aiming for sustainable value creation by partnering closely with ambitious management teams. As a recognized European market leader, Gimv manages a portfolio of around 60 companies representing roughly EUR 5 billion in combined turnover and more than 20,000 employees.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from public directories
What they invest in
from 15 of 18 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×7AI & Machine Learning ×3Digital Health ×3Hardware ×3Deep Tech ×2Energy ×2
HQs:Belgium×3Germany×3United States×3Switzerland×1Ireland×1Netherlands×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22023 · 12022 · 22020 · 28 dated
Teads operates an AI-powered omnichannel advertising platform that connects brands with audiences across screens, serving advertisers and publishers on the open internet.
AdTechAI & Machine LearningMarketing TechMedia & EntertainmentNew York City, US
Yaron Galai(Co-Founder and Chair of the Board)inEmmanuel FischmeisterinDavid Kostman(Chief Executive Officer and Director)in
Co-investorsJazzya InvestmentsLightspeed Venture PartnersStratim CapitalWind VentureElaiaGemini Israel Ventures+2 more
Itineris develops utility software solutions that help water and energy companies optimize operations, manage energy and water consumption, and support environmental goals.
AI & Machine LearningEnergyEnterprise SoftwareGovTechSaaSNot stated
Edgard Vermeersch(CEO & Founder)in
Paleo develops plant-based protein products designed to replicate the taste and qualities of animal meat, addressing sustainability in food production.
AgTechBiotechCircular EconomyClimate TechFoodTechImpact & Social Good
Hermes Sanctorum(Co-founder & CEO)inAndy de Jong(Co-founder & Board Director)in
BoardLieven De Smedt(Chairman of the Board)
Co-investorsSiddhi CapitalPlanet A Ventures
Topas Therapeutics develops nanoparticle-based therapies to induce immune tolerance for autoimmune and immune-mediated diseases.
BiotechHealthtech
Hugo Fry(Chief Executive Officer)inChristian Schröter(Chief Operating Officer)Cristina de Min(Chief Medical Officer)Anne Burger(Chief Financial Officer)Alex Marshall(Chief Business Officer)in
Co-investorsEMBL VenturesBoehringer Ingelheim Venture FundBioMedPartnersEpidarex Capital
BioConnection is a Contract Development and Manufacturing Organization (CDMO) specializing in filling, finishing, and lyophilizing injectable biopharmaceutical products.
Advanced ManufacturingBiotechHealthtechMedical DevicesOss, NL
Co-investorsBOM
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.
BiotechDigital HealthHealthtechMedical DevicesMunich, DE
Rafiq Hasan(CEO and Managing Director)inMuhammad Ali Memon(Chief Medical Officer)in
Co-investorsCambridge Innovation CapitalHadean VenturesSeroba Life SciencesBGVBioGeneration VenturesForbion+2 more
Complix develops therapeutic biologics based on Alphabody technology targeting viral diseases, oncology, and autoimmune conditions.
AI & Machine LearningBiotechDeep TechMedical Devices
Co-investorsPMVAndera PartnersVesalius Biocapital PartnersOmnes Capital
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.
Digital HealthHardwareMedical DevicesDublin, IE
Co-investorsAndera PartnersLightstone VenturesLongitude CapitalNew Enterprise Associates (NEA)Gilde HealthcareIreland Strategic Investment Fund+5 more
Hansea is a Belgian mobility company that provides customized passenger transport and integrated mobility solutions, including bus and coach rentals, through a network of more than 45 locations across Belgium.
Mobility & Transportation
Co-investorsCube Infrastructure Managers
ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.
BiotechHealthtech
Daniel Olive(Founder)
Co-investorsAgent CapitalAndera PartnersKurma PartnersPfizer Venture InvestmentsPureos BioventuresAlexandria+4 more
JenaValve develops transcatheter aortic valve replacement systems to treat severe aortic regurgitation and aortic stenosis.
Digital HealthHealthtechMedical DevicesIrvine, US
Hans Figulla(Director)Markus FerrariVictoria Carr-Brendel(Executive Officer, Director)David Drachman(Executive Officer, Director)
.jpg)
BoardArnd Kaltofen(Director)inErik Amble(Director)
Co-investorsAndera PartnersBain Capital Life SciencesVI PartnersAtlas VentureInnovatus Capital PartnersLegend Capital
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalEQT Life SciencesSixty Degree CapitalVivo Capital+3 more
SBS (Smart Battery Solutions) is a German manufacturer that develops, produces, and services lithium-ion batteries, covering the full product life cycle for various industries and applications such as warehouse robotics, industrial drones, rehab technology, light mobility, e-scooters, e-watercraft, e-bikes, and e-cargo.
EnergyHardwareMobility & Transportation
SynOx Therapeutics develops emactuzumab, a monoclonal antibody treatment for tenosynovial giant cell tumours (TGCT) and macrophage-mediated diseases.
BiotechHealthtechMedical Devices
Ray Barlow(Chief Executive Officer)in
Co-investorsHealthCapBioqube VenturesForbionMedicxi
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ERSSMGVariotech
Exits · 2
1 IPOs · 1 acquisitionsPortfolio news
latest coverage across their companiesKinaset Therapeutics · finsmes.com · Jan 12, 2026
JenaValve · nasdaqprivatemarket.com · Nov 20, 2025
Spineart · ggba.swiss · Oct 6, 2025
Itineris · itineris.net · Jun 23, 2025
Frequently asked questions
- How many investments has Gimv made?
- Gimv has 18 tracked investments, 2 of which have exited, including 3 dated in the last 24 months.
- What stage does Gimv invest at?
- Gimv invests at the Growth, Late Stage stages.
- What is Gimv's typical check size?
- Gimv typically writes checks of $21M – $430M.
- What sectors does Gimv focus on?
- Gimv focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Consumer, Data & Infrastructure, Energy, FoodTech, Hardware, Healthtech, Medical Devices, New Materials, SaaS, Semiconductors, Wellness & Fitness.
- Where is Gimv located?
- Gimv is headquartered in Antwerp, BE.
- Does Gimv lead rounds?
- Yes, Gimv leads investment rounds.
Images
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
VenturEast is one of India's longest-standing venture capital fund managers, investing since 1997 and managing over $325 million across more than 100 investments in technology, healthcare, and clean environment.
Horizon Technology Finance is a specialty finance company providing structured debt to technology and other venture-backed companies.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.